Previous studies have shown that SWELL1 is closely related to metabolic syndrome, cancer, and various other diseases, highlighting its enormous potential as a drug intervention target; however, the development of therapeutic drugs targeting the SWELL1 channel still faces many challenges (Gunasekar et al., 2022). The gene discussed is LRRC8A; the disease is cancer.